Davide Brusa

2.4k total citations
58 papers, 1.7k citations indexed

About

Davide Brusa is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Davide Brusa has authored 58 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Immunology, 17 papers in Molecular Biology and 14 papers in Oncology. Recurrent topics in Davide Brusa's work include Immunotherapy and Immune Responses (11 papers), Chronic Lymphocytic Leukemia Research (8 papers) and Immune Cell Function and Interaction (8 papers). Davide Brusa is often cited by papers focused on Immunotherapy and Immune Responses (11 papers), Chronic Lymphocytic Leukemia Research (8 papers) and Immune Cell Function and Interaction (8 papers). Davide Brusa collaborates with scholars based in Italy, Belgium and United States. Davide Brusa's co-authors include Silvia Deaglio, Sara Serra, Gianluca Gaïdano, Davide Rossi, Marta Coscia, Valentina Audrito, Lina Matera, Giorgio Inghirami, Fabio Malavasi and Tiziana Vaisitti and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and Blood.

In The Last Decade

Davide Brusa

53 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Davide Brusa Italy 23 717 673 517 260 223 58 1.7k
C. Christian Johansson Sweden 19 940 1.3× 590 0.9× 535 1.0× 195 0.8× 171 0.8× 29 1.7k
Sachiko Ezoe Japan 23 723 1.0× 607 0.9× 874 1.7× 228 0.9× 204 0.9× 55 2.0k
Dorota Wyczechowska United States 18 1.1k 1.6× 594 0.9× 881 1.7× 128 0.5× 650 2.9× 50 2.2k
Xiaohong Yao China 26 550 0.8× 783 1.2× 1.2k 2.2× 332 1.3× 614 2.8× 43 2.1k
Junmin Wu United States 18 710 1.0× 404 0.6× 1.1k 2.1× 77 0.3× 262 1.2× 28 2.2k
Jouko Sandholm Finland 22 474 0.7× 711 1.1× 818 1.6× 48 0.2× 171 0.8× 36 1.8k
Xinguo Jiang United States 27 414 0.6× 664 1.0× 569 1.1× 100 0.4× 254 1.1× 51 2.1k
Ralph K. Lindemann Germany 20 669 0.9× 421 0.6× 1.5k 2.8× 60 0.2× 197 0.9× 27 2.2k
Shaohua Chen China 26 1.4k 2.0× 1.2k 1.8× 1.0k 2.0× 216 0.8× 576 2.6× 184 3.0k

Countries citing papers authored by Davide Brusa

Since Specialization
Citations

This map shows the geographic impact of Davide Brusa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Davide Brusa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Davide Brusa more than expected).

Fields of papers citing papers by Davide Brusa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Davide Brusa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Davide Brusa. The network helps show where Davide Brusa may publish in the future.

Co-authorship network of co-authors of Davide Brusa

This figure shows the co-authorship network connecting the top 25 collaborators of Davide Brusa. A scholar is included among the top collaborators of Davide Brusa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Davide Brusa. Davide Brusa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Marino, Alice, Jérôme Ambroise, Martin Giera, et al.. (2025). Deleting ACC1 in platelets alters phospholipidome and reduces platelet activation and thrombosis in mice. Blood Advances. 9(18). 4553–4567.
2.
Lee, Yejin, Anne Lorant, Michaël Schnekenburger, et al.. (2025). TP53-agnostic lethality through combined pan-HDAC and CDK inhibition in acute myeloid leukemia. Cancer Letters. 633. 218011–218011.
3.
Bouzin, Caroline, Davide Brusa, Makram Merimi, et al.. (2025). Progression to fibrosis and hepatocellular carcinoma in DEN CCl4 liver mice, is associated with macrophage and striking regulatory T cells infiltration. Frontiers in Immunology. 16. 1601215–1601215.
4.
Stratopoulou, Christina Anna, Luciana Cacciottola, Davide Brusa, et al.. (2025). Impact of peritoneal macrophage depletion on endometriotic lesion development in a mouse model. 10. 100113–100113.
5.
Aubert, Léo, Estelle Bastien, Ophélie Renoult, et al.. (2024). Tumor acidosis-induced DNA damage response and tetraploidy enhance sensitivity to ATM and ATR inhibitors. EMBO Reports. 25(3). 1469–1489. 5 indexed citations
6.
Głowacka, Katarzyna, Ophélie Renoult, Charline Degavre, et al.. (2024). Acid-exposed and hypoxic cancer cells do not overlap but are interdependent for unsaturated fatty acid resources. Nature Communications. 15(1). 10107–10107. 2 indexed citations
7.
Rolla, Simona, Niccolò Rossi, Davide Brusa, et al.. (2021). Immune Trait Shifts in Association With Tobacco Smoking: A Study in Healthy Women. Frontiers in Immunology. 12. 637974–637974. 23 indexed citations
8.
Palmai‐Pallag, Mihaly, Yousof Yakoub, Saloua Ibouraadaten, et al.. (2021). Monocytic Ontogeny of Regenerated Macrophages Characterizes the Mesotheliomagenic Responses to Carbon Nanotubes. Frontiers in Immunology. 12. 666107–666107. 5 indexed citations
9.
Zampieri, Luca X., Debora Grasso, Caroline Bouzin, et al.. (2020). Mitochondria Participate in Chemoresistance to Cisplatin in Human Ovarian Cancer Cells. Molecular Cancer Research. 18(9). 1379–1391. 48 indexed citations
10.
Pauw, Aurélia De, et al.. (2019). Changes of Metabolic Phenotype of Cardiac Progenitor Cells During Differentiation: Neutral Effect of Stimulation of AMP-Activated Protein Kinase. Stem Cells and Development. 28(22). 1498–1513. 10 indexed citations
11.
Zotti, Flavia Dei, et al.. (2019). Redox regulation of nitrosyl-hemoglobin in human erythrocytes. Redox Biology. 34. 101399–101399. 16 indexed citations
12.
Saoncella, Stefania, Francesco Neri, Ugo Ala, et al.. (2017). Rictor/mTORC2 deficiency enhances keratinocyte stress tolerance via mitohormesis. Cell Death and Differentiation. 24(4). 731–746. 23 indexed citations
13.
Orso, Francesca, Federico Virga, Elisa Penna, et al.. (2016). miR-214 and miR-148b Targeting Inhibits Dissemination of Melanoma and Breast Cancer. Cancer Research. 76(17). 5151–5162. 61 indexed citations
14.
Audrito, Valentina, Sara Serra, Davide Brusa, et al.. (2014). Extracellular nicotinamide phosphoribosyltransferase (NAMPT) promotes M2 macrophage polarization in chronic lymphocytic leukemia. Blood. 125(1). 111–123. 154 indexed citations
15.
Massi, Daniela, Davide Brusa, Barbara Merelli, et al.. (2014). PD-L1 marks a subset of melanomas with a shorter overall survival and distinct genetic and morphological characteristics. Annals of Oncology. 25(12). 2433–2442. 129 indexed citations
16.
Brusa, Davide, Sara Serra, Marta Coscia, et al.. (2013). The PD-1/PD-L1 axis contributes to T-cell dysfunction in chronic lymphocytic leukemia. Haematologica. 98(6). 953–963. 186 indexed citations
17.
Rizzo, Roberta, Valentina Audrito, Paola Vacca, et al.. (2013). HLA-G is a component of the chronic lymphocytic leukemia escape repertoire to generate immune suppression: impact of the HLA-G 14 base pair (rs66554220) polymorphism. Haematologica. 99(5). 888–896. 44 indexed citations
18.
Kopecka, Joanna, Davide Brusa, Elena Gazzano, et al.. (2009). iNOS activity is necessary for the cytotoxic and immunogenic effects of doxorubicin in human colon cancer cells. Molecular Cancer. 8(1). 108–108. 73 indexed citations
19.
Brusa, Davide, Stefano Garetto, Giovanna Chiorino, et al.. (2008). Post-apoptotic tumors are more palatable to dendritic cells and enhance their antigen cross-presentation activity. Vaccine. 26(50). 6422–6432. 48 indexed citations
20.
Brusa, Davide, et al.. (2007). Contribution of dendritic cells FcγRI and FcγRIII to cross-presentation of tumor cells opsonized with the anti-MHC class I monoclonal antibodies. Cancer Biology & Therapy. 6(12). 1932–1937. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by C. Christian Johansson Breakdown of academic impact, for papers by Sachiko Ezoe Breakdown of academic impact, for papers by Dorota Wyczechowska Breakdown of academic impact, for papers by Xiaohong Yao Breakdown of academic impact, for papers by Junmin Wu Breakdown of academic impact, for papers by Jouko Sandholm Breakdown of academic impact, for papers by Xinguo Jiang Breakdown of academic impact, for papers by Ralph K. Lindemann Breakdown of academic impact, for papers by Shaohua Chen
Rankless by CCL
2026